Adjuvant Therapy for HER2-Negative Early Breast Cancer: Interactive Decision Support Tool

Content Format:

Tool

Credit Type:

--

Credits:

--
Key Studies in Breast Cancer: Independent Conference Coverage of the 2024 ASCO Annual Meeting

Content Format:

Text Module

Credit Type:

AMA

Credits:

0.75
Clinical Dilemmas When Selecting Adjuvant Therapy for HER2-Negative Early-Stage Breast Cancer

Content Format:

Clinical Thought

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

0.25
Conference to Clinic: Breast Cancer

Content Format:

Video

Credit Type:

AMA

Credits:

1.00
Conference to Clinic: Breast Cancer

Content Format:

Slideset

Credit Type:

--

Credits:

--
Comparison of expert treatment recommendations vs community healthcare providers: analysis from an online decision support tool for metastatic breast cancer

Content Format:

PDF

Credit Type:

--

Credits:

--
An Expert’s Guide to ASCO 2024: Preview of the Top Abstracts

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
Expert Perspectives on Novel and Emerging HER2-Directed and TROP-2‒Targeted ADCs for Advanced Breast Cancer

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Sequencing Treatment in HER2-Positive Metastatic Breast Cancer

Content Format:

Video

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

0.75
Sequencing Treatment in HER2-Positive Metastatic Breast Cancer

Content Format:

Slideset

Credit Type:

--

Credits:

--
Making Treatment Decisions for Metastatic Breast Cancer: An Interactive Decision Support Tool for Patients

Content Format:

Tool

Credit Type:

--

Credits:

--
Next-Generation Endocrine Therapies for ER+/HER2- Breast Cancer Care: Key Takeaways From Our Recent Symposium in San Antonio

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Next-Generation Endocrine Therapies: Opportunities in ER+/HER2- Breast Cancer Care

Content Format:

Video

Credit Type:

AMA

Credits:

1.25
New Options in High-Risk Early Breast Cancer

Content Format:

Video

Credit Type:

AAPA | ANCC

Credits:

1.00
My Experience Managing Key Adverse Events With Oral Targeted Therapy for High-Risk Early Breast Cancer

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Navigating Endocrine Therapy and Resistance in ER+/HER2- Breast Cancer

Content Format:

Slideset

Credit Type:

--

Credits:

--
Oral SERDs and Novel Endocrine Therapies: Reshaping the Treatment Landscape for ER+/HER2- Breast Cancer

Content Format:

Slideset

Credit Type:

--

Credits:

--
New Options in High-Risk Early Breast Cancer

Content Format:

Slideset

Credit Type:

--

Credits:

--
Interactive Decision Support Tool: Expert Treatment Guidance for Metastatic Breast Cancer

Content Format:

Tool

Credit Type:

--

Credits:

--
(Neo)Adjuvant Therapy in HER2-Negative Early Breast Cancer Treatment Selection Tool

Content Format:

Tool

Credit Type:

--

Credits:

--
Expert Review of Treatment for HER2-Negative Early Breast Cancer

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
Expert Review of Treatment for HER2-Negative Early Breast Cancer

Content Format:

Slideset

Credit Type:

--

Credits:

--
Healthcare Professional Checklist for Patient Communication in HER2-Negative Early Breast Cancer

Content Format:

PDF

Credit Type:

--

Credits:

--
An Interactive Treatment Decision Tool for HER2-Negative Early Breast Cancer

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
(Neo) Adjuvant Therapy in HER2-Negative Early Breast Cancer Treatment Selection Tool

Content Format:

Tool

Credit Type:

--

Credits:

--
New Data, New Opportunities, and New Clinical Challenges Using Immunotherapies for TNBC

Content Format:

Video

Credit Type:

AMA

Credits:

1.25
How I Sequence Recently Approved Immunotherapies in Advanced TNBC With vs Without BRCA Mutation

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
ExpressPoints: New Opportunities and Clinical Challenges Using Immunotherapies for TNBC

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Antibody–Drug Conjugates in TNBC

Content Format:

Slideset Download

Credit Type:

--

Credits:

--